{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:02:01Z","timestamp":1778770921506,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.bone.2021.115864","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T01:56:11Z","timestamp":1611626171000},"page":"115864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Bone metabolic marker concentrations across the menstrual cycle and phases of combined oral contraceptive use"],"prefix":"10.1016","volume":"145","author":[{"given":"Dan","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon B.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C.Y.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Sale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty J.","family":"Elliott-Sale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.115864_bb0005","first-page":"1904","article-title":"The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation 1","volume":"82","author":"Rosen","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.115864_bb0010","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/clinchem\/48.5.754","article-title":"Changes in bone turnover in patients with anorexia nervosa during eleven weeks of inpatient dietary treatment","volume":"48","author":"Heer","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bone.2021.115864_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bone.2018.06.016","article-title":"Bone metabolic responses to low energy availability achieved by diet or exercise in active eumenorrheic women","volume":"114","author":"Papageorgiou","year":"2018","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.115864_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bone.2015.11.005","article-title":"Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population","volume":"83","author":"Dai","year":"2016","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.115864_bb0025","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00198-019-05043-1","article-title":"Biochemical markers of bone turnover and risk of incident hip fracture in older women: the cardiovascular health study","volume":"30","author":"Massera","year":"2019","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.115864_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.115864_bb0035","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00198-017-4082-4","article-title":"Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability","volume":"28","author":"Szulc","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.115864_bb0040","first-page":"182","article-title":"Clinical profile of contraceptive progestins","volume":"9","author":"Benagiano","year":"2004","journal-title":"Eur. J. Contracept. Reprod. Heal. Care."},{"key":"10.1016\/j.bone.2021.115864_bb0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0010-7824(90)90001-C","article-title":"Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users","volume":"42","author":"Van Der Spuy","year":"1990","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0010-7824(99)00025-6","article-title":"Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives","volume":"59","author":"Van Heusden","year":"1999","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.contraception.2006.02.006","article-title":"Greater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free interval","volume":"74","author":"Willis","year":"2006","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0029-1211124","article-title":"Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations","volume":"99","author":"Carol","year":"1992","journal-title":"Exp. Clin. Endocrinol. & Diabetes"},{"key":"10.1016\/j.bone.2021.115864_bb0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0010-7824(92)90149-N","article-title":"Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation","volume":"46","author":"Kuhnz","year":"1992","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(91)90122-V","article-title":"Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months","volume":"43","author":"Dibbelt","year":"1991","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000182110","article-title":"Concentration of ethinyl estradiol in the serum of 31 young women following a treatment period of 3 months with two low-dose oral contraceptives in an intraindividual cross-over design","volume":"36","author":"Kuhnz","year":"1991","journal-title":"Horm. Res."},{"key":"10.1016\/j.bone.2021.115864_bb0080","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/09513590009167670","article-title":"Induction of estrogen receptor-alpha and -beta activities by synthetic progestins","volume":"14","author":"Rabe","year":"2000","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.bone.2021.115864_bb0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13625180008500387","article-title":"A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel","volume":"5","author":"Foidart","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.bone.2021.115864_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0010-7824(00)00106-2","article-title":"Collagen metabolism markers as a reflection of bone and soft tissue turnover during the menstrual cycle and oral contraceptive use","volume":"61","author":"Wreje","year":"2000","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0095","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0002-9378(96)70052-2","article-title":"Serum relaxin, symphyseal pain, and back pain during pregnancy","volume":"175","author":"Kristiansson","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bone.2021.115864_bb0100","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/BF02284965","article-title":"Influence of oral contraceptive agents on kidney function and protein metabolism","volume":"43","author":"Br\u00e4ndle","year":"1992","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2021.115864_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1471-0528.1981.tb00930.x","article-title":"Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy","volume":"88","author":"Davison","year":"1981","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.bone.2021.115864_bb0110","first-page":"585","article-title":"Effect of the menstrual cycle on creatinine clearance in normally cycling women","volume":"92","author":"Phipps","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.bone.2021.115864_bb0115","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/gme.0b013e31815f8917","article-title":"Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women","volume":"15","author":"Gass","year":"2008","journal-title":"Menopause."},{"key":"10.1016\/j.bone.2021.115864_bb0120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12020-016-1056-9","article-title":"Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study","volume":"54","author":"Liakou","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.bone.2021.115864_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00774-013-0430-4","article-title":"Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle","volume":"31","author":"Mozzanega","year":"2013","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2021.115864_bb0130","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1055\/s-0035-1558298","article-title":"Non-reproductive effects of anovulation: bone metabolism in the luteal phase of premenopausal women differs between ovulatory and anovulatory cycles","volume":"75","author":"Niethammer","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.bone.2021.115864_bb0135","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1242\/jcs.063032","article-title":"Bone remodelling at a glance","volume":"124","author":"Crockett","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bone.2021.115864_bb0140","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1359\/jbmr.1999.14.4.609","article-title":"Changes in bone resorption during the menstrual cycle","volume":"14","author":"Chiu","year":"1999","journal-title":"J.Bone Miner.Res."},{"key":"10.1016\/j.bone.2021.115864_bb0145","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1210\/jcem-70-5-1431","article-title":"Changes in biochemical markers of osteoblastic activity during the menstrual cycle*","volume":"70","author":"Nielsen","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.115864_bb0150","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.contraception.2012.11.023","article-title":"Examining the role of oral contraceptive users as an experimental and\/or control group in athletic performance studies","volume":"88","author":"Elliott-Sale","year":"2013","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.bone.2021.115864_bb0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s002230020035","article-title":"Oral contraceptives moderately effect bone resorption markers and serum-soluble interleukin-6 receptor concentrations","volume":"70","author":"Zittermann","year":"2002","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2021.115864_bb0165","first-page":"143","article-title":"Oestrogen action on bone cells","volume":"2","author":"Krassas","year":"2001","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bone.2021.115864_bb0170","series-title":"Serum Soluble Interleukin-6 Receptor and Biochemical Markers of Bone Metabolism Show Significant","first-page":"326","volume":"83","author":"Gorai","year":"2014"},{"key":"10.1016\/j.bone.2021.115864_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2003.10.002","article-title":"A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 \u03bcg or 30 \u03bcg ethinylestradiol in combination with levonorgestrel on bone mineral density","volume":"69","author":"Endrikat","year":"2004","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0180","first-page":"285","article-title":"Variations in circulating osteoprotegerin and soluble RANKL during diurnal and menstrual cycles in young women","volume":"71","author":"Shimizu","year":"2009","journal-title":"Horm. Res."},{"key":"10.1016\/j.bone.2021.115864_bb0185","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/8756-3282(95)00075-O","article-title":"Decreased bone turnover in oral contraceptive users","volume":"16","author":"Garnero","year":"1995","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.115864_bb0190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1359\/jbmr.080703","article-title":"Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States","volume":"24","author":"Glover","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115864_bb0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF01623817","article-title":"Oral contraception affects osteocalcin serum profiles in young women","volume":"2","author":"Karlsson","year":"1992","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.115864_bb0200","first-page":"179","article-title":"Effects of contraceptive use on bone biochemical markers in young women1","volume":"86","author":"Ott","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.115864_bb0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.contraception.2004.04.004","article-title":"Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30\u202f??g of ethinyl estradiol: observational study in young postadolescent women","volume":"70","author":"Paoletti","year":"2004","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jpag.2004.09.013","article-title":"Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive","volume":"17","author":"Rome","year":"2004","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.bone.2021.115864_bb0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2008.01.016","article-title":"Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study","volume":"78","author":"Gargano","year":"2008","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0220","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0010-7824(03)00025-8","article-title":"Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study","volume":"67","author":"Nappi","year":"2003","journal-title":"Contraception."},{"key":"10.1016\/j.bone.2021.115864_bb0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.AOG.0000148344.26475.fc","article-title":"Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density","volume":"105","author":"Nappi","year":"2005","journal-title":"Obstet. Gynecol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:53:29Z","timestamp":1757613209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":45,"alternative-id":["S8756328221000260"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.115864","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone metabolic marker concentrations across the menstrual cycle and phases of combined oral contraceptive use","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.115864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115864"}}